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Alternative Lengthening of Telomeres (ALT) is a Break-Induced Replication (BIR)-based
mechanism elongating telomeres in a subset of human cancer cells. While the notion that
spontaneous DNA damage at telomeres is required to initiate ALT, the molecular triggers of
this physiological telomere instability are largely unknown. We previously proposed that the
telomeric long noncoding RNA TERRA may represent one such trigger; however, given the
lack of tools to suppress TERRA transcription in cells, our hypothesis remained speculative.
We have developed Transcription Activator-Like Effectors able to rapidly inhibit TERRA
transcription from multiple chromosome ends in an ALT cell line. TERRA transcription inhi-
bition decreases marks of DNA replication stress and DNA damage at telomeres and impairs
ALT activity and telomere length maintenance. We conclude that TERRA transcription
actively destabilizes telomere integrity in ALT cells, thereby triggering BIR and promoting
telomere elongation. Our data point to TERRA transcription manipulation as a potentially
useful target for therapy.
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Transcription of telomeric DNA into the long noncodingRNA TERRA is an evolutionarily conserved feature ofeukaryotic cells with linear chromosomes1. RNA poly-
merase II produces TERRA proceeding from subtelomeric
regions towards chromosome ends and using the C-rich telomeric
strand as a template. As a result, TERRA molecules comprise
chromosome-specific subtelomeric sequences followed by a
variable number of telomeric UUAGGG repeats2–4. TERRA is
found either dispersed throughout the nucleoplasm or associated
with telomeric chromatin, as well as other genomic loci that
contain or not telomeric DNA repeats4–7. The molecular
mechanisms mediating TERRA retention on chromosomes still
need to be fully elucidated; however, the propensity of TERRA to
form RNA:DNA hybrids with its template DNA strand (telomeric
R-loops or telR-loops)8–11 and the physical interaction of human
TERRA with the shelterin factors TRF1 and TRF212,13 suggest
that TERRA association with telomeric DNA-containing loci
involves RNA–DNA and RNA–protein interactions.
The chromosomal origin of human TERRA is controversial.
Using RT-PCR and Illumina sequencing, independent labora-
tories reported on the existence of TERRA molecules originating
from a multitude of chromosome ends3,14–19. Consistently, we
previously identified CpG dinucleotide-rich tandem repeats of
29 bp displaying promoter activity and located on approximately
half of chromosome ends2. 29 bp repeats are positioned at vari-
able distances from the first telomeric repeat and their tran-
scriptional activity is repressed by CpG methylation2. Moreover,
transcription factor binding sites exist on multiple subtelomeres
and inactivation of some of them alter TERRA levels in
cells14,20–22. However, work from the Blasco laboratory, based on
re-analysis of TERRA Illumina sequencing data and molecular
and cell biological validation experiments, posed that human
TERRA is mainly transcribed from one unique locus on the long
arm of the chromosome 20 (20q) subtelomere23,24. The same
group used CRISPR/Cas9 to delete a 8.1 kb fragment from the
20q subtelomere comprising 4 putative promoters in U2OS
osteosarcoma cells and isolated several clonal lines (20q-TERRA
KO cells). Seemingly supporting the proposed origin of TERRA,
20q-TERRA KO cells displayed substantially diminished total
TERRA levels when compared to parental cells23,24.
TERRA is involved in several telomere-associated processes
including telomerase recruitment and regulation, telomeric DNA
replication, telomeric heterochromatin establishment, response to
DNA damage at telomeres and replicative senescence initiation1.
Our laboratory and others have implicated TERRA also in telo-
mere elongation in telomerase-negative cancer cells with an
activated Alternative Lengthening of Telomeres (ALT)
mechanism8,9,24,25. ALT is a specialized pathway repairing and
thus re-elongating damaged telomeres through Break-Induced
Replication (BIR) occurring in the G2 and M phases of the cell
cycle and requiring the DNA polymerase delta accessory subunits
POLD3 and POLD425–29. Consistent with a function for TERRA
in ALT, human ALT cells, including U2OS, are characterized by
elevated telomeric transcription and TERRA levels and abundant
telR-loops2,8,15. Moreover, the RNA:DNA endoribonuclease
RNaseH1 and the ATPase/helicase FANCM dismantle telR-loops
and FANCM restricts total TERRA levels specifically in ALT cells.
Because RNaseH1 and FANCM inactivation increase telomere
instability and ALT activity, while their over-expression alleviates
ALT8,9,30,31, we proposed that physiological damage triggered by
TERRA/telR-loops at ALT telomeres may provide the substrate
for BIR-mediated telomere elongation8,9,32,33. However, due to a
lack of tools to rapidly suppress TERRA transcription in cells, our
hypothesis remained speculative. Further challenging our
hypothesis, 20q-TERRA KO cells show increased telomeric
localization of the DNA damage factors γH2AX and 53BP1 and
telomeric fusions24, which has been interpreted as evidence for
TERRA capping, rather than destabilizing, telomeres in ALT cells.
Results
Development of Transcription Activator-Like Effectors bind-
ing to 29 bp repeats. To assess the short-term impact of TERRA
transcription on telomere stability in ALT cells we engineered
Transcription Activator-Like Effectors (TALEs)34 targeting a
20 bp sequence within the 29 bp repeat consensus2 (herein
referred to as T-TALEs; Fig. 1a). Variable numbers of exact 20 bp
sequences are found within the last 3 kb of 20 subtelomeres (3p,
5p, 9p, 12p, 16p, 19p, 1q, 2q, 4q, 5q, 6q, 10q, 11q, 13q, 15q, 16q,
19q, 21q, 22q, and Xq/Yq). T-TALEs were C-terminally fused to a
strong nuclear localization signal (NLS), four transcription
repressor domains of the mSIN3 interaction domain (Enhanced
Repressor Domain, SID4X), and a human influenza hemagglu-
tinin (HA) epitope (Fig. 1a). T-TALEs not fused to SID4X were
used as controls. Transgenes were cloned downstream of a dox-
ycycline (dox) inducible promoter and stably integrated in U2OS
cells expressing the tetracycline repressor protein. Several clonal
cell lines were isolated in absence of dox and successively tested
for dox-induced T-TALE expression by western blot and indirect
immunofluorescence (IF) using anti-HA antibodies. Two inde-
pendent cell lines for SID4X-fused T-TALEs (sid1 and sid4) and
two for unfused T-TALEs (nls1 and nls3) were chosen for further
experiments because: (i) transgene expression was almost unde-
tectable in absence of dox; and (ii) dox treatments induced
expression of ectopic proteins homogeneously distributed across
the cell population, properly localized to the nucleus and at fairly
similar levels in the four cell lines (Fig. 1a and Supplementary
Fig. 1a–c).
To confirm T-TALE binding specificity, we treated nls3, sid4,
and parental U2OS cells with dox for 24 h and performed
chromatin immunoprecipitations (ChIPs) with anti-HA anti-
bodies followed by qPCR using oligonucleotide amplifying
subtelomeric sequences from several chromosome ends either
containing or not 29 bp repeat sequences (29 bp+ and 29 bp−,
respectively). DNA in very close proximity of 29 bp repeats on
chromosomes 9p, 10q, 15q, 16p, and Xq subtelomeres was
enriched in nls3 and sid4 ChIP samples over parental U2OS
samples. The enrichment diminished for sequences more distant
from the 29 bp repeats on the same subtelomeres (Fig. 1b and
Supplementary Table 1). On the contrary, no enrichment was
observed for DNA from 29 bp− subtelomeres (10p, 12q, 18p,
20q, and Xp), the centromere of the X chromosome, centromeric
alphoid repeats, and the beta Actin or U6 gene loci (Fig. 1b and
Supplementary Table 1). This confirms that T-TALEs specifically
bind to 29 bp repeat.
T-TALEs rapidly suppress TERRA transcription from 29 bp
repeat-containing chromosome ends. To test the functionality of
T-TALEs, we treated cells with dox for 24 h and performed RT-
qPCR to measure TERRA from 29 bp+ (9pXq, 10q, 15q, and 16p)
and 29 bp− (10p18p, 12q, 20q, and Xp) subtelomeres. In sid1 and
sid4 cells, TERRA from 29 bp+ subtelomeres was greatly reduced
while TERRA from 29 bp− was not affected. In nls1 and nls3 cells,
no significant change in TERRA levels was observed at any
chromosome ends (Fig. 1c). Northern blot hybridization of total
RNA with a C-rich telomeric repeat probe did not detect sub-
stantial variations across sid and nls cells treated or not with dox
for 24 h (Supplementary Fig. 2). Hence, TERRA from 29 bp repeat
promoters does not majorly contribute to the cellular pool of
UUAGGG repeats. Moreover, because TERRA transcription from
29 bp− chromosome ends is not affected in dox-treated sid cells
(Fig. 1c), an immediate cross-talk between the transcriptional state
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of independent telomeres appears not to exist in U2OS cells.
However, a larger number of ends would need to be tested to
corroborate this conclusion.
Fluorescence-activated cell sorting (FACS) of propidium iodide
(PI)-stained cells did not uncover cell-cycle profile alterations in
dox-treated nls and sid cells as compared to untreated controls
(Supplementary Fig. 3a, b); this indicates that the TERRA
decrease observed in sid1 and sid4 cells is not an indirect
consequence of a disturbed cell-cycle progression. Further
supporting this notion, in ALT cells, TERRA levels do not
diminish when the cell-cycle progresses from S to G2 phases, as
typical in telomerase positive cells4,35. Hence, our TALE-based
system can efficiently and specifically inhibit TERRA transcrip-
tion from 29 bp promoter repeats.
TERRA transcription suppression alleviates telomere instabil-
ity. To probe the effects of TERRA transcription inhibition on
telomere stability, we performed indirect immunofluorescence
(IF) using antibodies against the single-stranded DNA binding
protein RPA32, RPA32 phosphorylated at serine 33 (pSer33)
or γH2AX combined with either telomeric DNA fluorescence
in situ hybridization (FISH) or IF against the shelterin compo-
nent TRF2. RPA32 and pSer33 were used as markers of DNA
replication stress, while γH2AX as a broad DNA damage marker.
Dox treatments diminished the telomeric localization of both
RPA32 variants in sid1 and sid4 cells (Fig. 2a, b and Supple-
mentary Fig. 4) already at 24 h after drug delivery. A slightly
sharper decrease was observed for total RPA32 than for pSer33,
suggesting that a fraction of the protein binds to telomeres
independently of serine 33 phosphorylation or that the protein
undergoes dephosphorylation while still telomere-bound. Simi-
larly, dox treatments diminished the frequencies of γH2AX co-
localization with telomeres in sid1 and sid4 cells (Fig. 2a, b, and
Supplementary Fig. 4). Dox treatments did not alter co-
localization frequencies for any of the tested markers in nls1
and nls3 cells (Fig. 2a, b and Supplementary Fig. 4). Moreover,
dox did not affect the total cellular levels of RPA32, pSer33,
γH2AX, and TRF2 nor did it impair RPA32 and H2AX phos-
phorylation when cells were simultaneously treated with the
damaging agent camptothecin (Supplementary Fig. 1c). Hence, all
changes observed in dox-treated sid1 and sid4 cells do not derive
from altered protein cellular levels or from a compromised DNA
damage response. Alterations in cell-cycle distribution also can-
not account for the observed changes in RPA32, pSer33, and
γH2AX at telomeres (Supplementary Fig. 3a, b).
TERRA transcription suppression inhibits ALT activity.
According to our model, diminished telomere instability should
Fig. 1 Development and validation of T-TALEs. a Schematic representation of T-TALEs. The RVD domain recognizing the indicated nucleotides within the
29 bp repeat consensus sequence is represented by gray rounded rectangles. NLS: nuclear localization signal; SID4X: four transcription repressor domains
of the mSIN3 interaction domain; HA: human influenza hemagglutinin tag. b Quantification of anti-HA ChIPs in the indicated cell lines (parental: T-Rex-
U2OS) treated with dox for 24 h. QPCRs were performed with oligonucleotides amplifying subtelomeric regions from chromosome ends containing or
devoid of 29 bp repeats (29 bp+ and 29 bp−, respectively). For 29 bp+ subtelomeres, two oligonucleotide pairs placed at different distances from the
29 bp array were used and are indicated as near and far. The distances of each amplicon from 29 bp repeats and/or telomeric repeats are shown in
Supplementary Table 1. Control qPCR was performed with oligonucleotides amplifying sequences from a unique region of the X chromosome centromere
(Xcen), alphoid DNA (Alph), and beta Actin (ACTB) and U6 gene loci. Values are graphed as input DNA found in the corresponding ChIP samples
normalized to U2OS parental samples. Bars and error bars are means and SEMs from three independent experiments. Circles are single data points. c RT-
qPCR quantifications of TERRA transcripts from 29 bp+ and 29 bp− chromosome ends in the indicated cell lines, treated with dox for 24 h or left
untreated. Values are graphed normalized to −dox. Bars and error bars are means and SEMs from 3 independent experiments for 9pXq and 20q and from
4 independent experiments for the remaining chromosome ends. Circles are single data points. P-values were calculated with a two-tailed Student’s t-test.
P1= 0.01886; P2= 0.0065; P3= 0.0325; P4= 0.0059; P5= 0.00442; P6 < 0.0001; P7= 0.0006; P8= 0.0022. Source data are provided as a Source
Data file.
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weaken ALT activity. To test this, we first quantified ALT-
associated PML bodies (APBs) by combining IF with an anti-
PML antibody and telomeric DNA FISH. APBs diminished in
sid1 and sid4 but not in nls1 and nls3 cells already 24 h after
adding dox (Fig. 3a, b and Supplementary Fig. 4). We then
synchronized cells at the G1/S transition and let them progress
from S-phase to G2 in presence of dox and the Cdk1 inhibitor
RO-3306. Cells were pulsed with EdU during the last 2.5 h of
treatment and subjected to EdU detection combined with telo-
meric DNA FISH. Dox did not affect the frequencies of EdU co-
localization with telomeric DNA in nls1 and nls3 cells, while it
substantially diminished them in sid1 and sid4 cells (Fig. 3a, b
and Supplementary Fig. 4). This suggests that dox treatments
reduced telomeric BIR in G2 synchronized sid cells. Consistently,
as shown by double IF experiments, dox diminished the fre-
quencies of POLD3 co-localization with the shelterin component
RAP1 in sid1 and sid4, but not in nls1 and nls3 G2 cells (Fig. 3a, b
and Supplementary Fig. 4). Changes in APBs and POLD3 telo-
meric localization occurred in absence of changes in PML,
POLD3, and RAP1 total protein levels (Supplementary Fig. 1b).
Moreover, dox treatments did not affect the efficiency of our
synchronization protocol (Supplementary Fig. 3a, b). Thus, the
decline in ALT features observed in sid1 and sid4 cells cannot be
ascribed to altered protein levels or differences in the fraction of
cells in the G2 phase.
As additional markers of ALT activity, we also quantified C-
circles, which are circular telomeric DNA molecules with exposed
single-stranded C-rich tracts, and telomeric sister chromatid
exchanges (TSCEs)26. C-circle assays with total genomic DNA
did not disclose consistent changes in nls1, sid1, and sid4 cells
treated with dox for up to 72 h. In nls3 cells, C-circle levels
diminished after 24 h of treatment and started to recover at later
time points (Supplementary Fig. 5a, b). Chromosome orientation
FISH (CO-FISH) on nls3 and sid4 metaphase chromosomes did not
detect significant changes in TSCE frequencies associated with dox
treatments in either cell line (Fig. 4a–c). However, we noticed
unequal distribution of leading and lagging strand signals at several
chromosome ends. Thus, we also quantified the occurrence of sister
telomeres with 2 leading and one lagging strand signals (double
leading or DLead) and with 2 lagging and one leading strand signals
(double lagging or DLagg). DLagg telomeres were not affected by
dox treatments in both cell lines, while DLead telomeres were more
than halved in sid4 but not nls3 dox-treated cells as compared to
untreated controls (Fig. 4a–c).
Fig. 2 TERRA transcription inhibition alleviates telomere instability. a Examples of RPA32, pSer33, or γH2AX IF (green) combined with telomeric DNA
FISH (teloDNA) or TRF2 IF (red). DAPI-stained DNA is in blue. The indicated cell lines were treated with dox for 24 h for RPA32 and pSer33 or 72 h for
γH2AX. Arrowheads in the merge panels point to co-localization events. Scale bar: 5 μm. b Quantifications of experiments as in a. Boxplots represent the
medians (middle lines) and the first and third quartiles (boxes), the whiskers extend to the 90th percentile of the values. A total of at least 300 nuclei from
three independent experiments were analyzed for each sample. P-values were calculated with a two-tailed Mann–Whitney U test. P1= 0.0008;
P2= 0.0010; P3= 0.0511; P4= 0.0080; P5 < 0.0001; P6 < 0.0001. Source data are provided as a Source Data file.
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TERRA transcription suppression impairs telomere main-
tenance. Alleviation of ALT activity should translate into
impaired telomere elongation and progressive loss of telomeric
DNA. We treated cells with dox over a prolonged time course and
analyzed telomeres by telomeric DNA FISH on metaphase
chromosomes. A progressive, statistically significant accumula-
tion of telomere free ends (TFEs) was observed in sid1 and sid4
cells treated with dox for up to 15 and 9 days, respectively
(Fig. 5a, b). Conversely, no significant change in TFEs was
observed in nls3 cells during the tested time course (Fig. 5a, b).
We also inspected the state of telomeres in nls3, sid1, and sid4
cells treated with dox for 15 days by telomere restriction fragment
analysis combined with pulse-field gel electrophoresis (PFGE).
No major differences were observed in the length of the bulk
telomeres (comprised between 10 and 63.5 kb) or in the asso-
ciated signal intensity when comparing dox-treated and untreated
samples (Supplementary Fig. 6). This indicates that the TFEs
induced by TERRA transcription inhibition mostly accumulate at
shorter telomeres, which are not detected in PFGE. This is con-
sistent with shorter telomeres having higher transcriptional
activity5,16,36 and thus being primarily affected by its inhibition.
We then tested whether crippling the ALT BIR machinery
causes the same telomeric defects observed in dox-treated sid1
and sid4 cells. We depleted POLD3 in U2OS cells using two
independent siRNAs for 6 days (Supplementary Fig. 1d) and
performed metaphase telomeric DNA FISH. POLD3 depletion
increased TFE frequencies by almost three-fold as compared to
siRNA control-transfected cells (Fig. 5a, b). We conclude that
impairing BIR through TERRA transcription inhibition or
POLD3 depletion causes substantial loss of telomeric DNA in a
relatively short time frame. In agreement with this conclusion, we
previously reported that over-expressing RNaseH1 in several ALT
cell lines resolves telR-loops and increases TFEs within a period
of 6 to 13 days8.
TERRA transcription suppression leads to transcriptomic
changes. TERRA depletion in mouse ES cells caused significant
changes in gene expression7. We, therefore, performed RNA-seq of
total RNA prepared from nls3 and sid4 cells treated with dox for 72 h
or left untreated. Comparative analysis of dox-treated versus
untreated samples identified significant (Benjamini–Hochberg cor-
rected P ≤ 0.05) differential expression of 3063 transcripts (2574
protein coding and 489 noncoding transcripts) in sid4 cells; of those
transcripts, 1928 were upregulated and 1135 downregulated (Fig. 6a
and Supplementary Data 1). In nls3 cells treated with dox, only 15
Fig. 3 TERRA transcription inhibition alleviates ALT activity. a Left and right panels: examples of PML or POLD3 IF (green) combined with telomeric DNA
FISH (teloDNA) or RAP1 IF (red). Middle panels: examples of EdU detection (green) combined with telomeric DNA FISH (red). DAPI-stained DNA is in
blue. The indicated cell lines were treated with dox for 24 h for PML or for 24.5 h for POLD3 and EdU (G2 synchronized cells, see methods for details).
Arrowheads in the merge panels point to co-localization events. Scale bar: 5 μm. b Quantifications of experiments as in a. Boxplots represent the medians
(middle lines) and the first and third quartiles (boxes), the whiskers extend to the 90th percentile of the values. A total of at least 300 nuclei from three
independent experiments were analyzed for each sample. P-values were calculated with a two-tailed Mann–Whitney U test. P1= 0.0169; P2 < 0.0001;
P3= 0.0193; P4= 0.0812; P5 < 0.0001; P6= 0.0063. Source data are provided as a Source Data file.
NATURE COMMUNICATIONS | https://doi.org/10.1038/s41467-021-24097-6 ARTICLE
NATURE COMMUNICATIONS |         (2021) 12:3760 | https://doi.org/10.1038/s41467-021-24097-6 |www.nature.com/naturecommunications 5
transcripts (13 protein coding and 2 noncoding) were differentially
expressed, 6 being upregulated and 9 downregulated (Supplementary
Data 1). Transcript level alterations in sid4 cells were overall mod-
erate, with only 226 and 236 transcripts showing a log2 fold change
of at least 1 or −1, respectively (Supplementary Data 1). Hence,
TERRA transcription suppression is associated with mild yet sig-
nificant transcriptomic changes in human ALT cells. Gene Ontology
Biological Process (GO-BP) analysis identified alterations of tran-
scripts significantly enriched in 196 GO-BP terms (false discovery
rate [FDR] P ≤ 0.05) and traceable to 12 main biological processes
including nervous system development, cell movement, cell-cycle
progression, and cell death (Fig. 6b and Supplementary Data 2).
Interestingly, we observed significant upregulation of transcripts
involved in vacuole organization and autophagy, and downregulation
of transcripts involved in apoptotic cell death (Supplementary Fig. 7
and Supplementary Data 2).
We also noticed a differential expression of transcripts involved
in DNA metabolism and identify 11 protein-coding transcripts
(downregulated: ORC1, RAD51AP1, BRCA2, GEN1, ORC6,
BRCA1, HROB, BLM, EXO1, FANCD2; upregulated: LIG4)
whose altered expression could alleviate telomere instability and
ALT activity (Fig. 6a). Despite the differential expression of those
transcripts being borderline significant, we quantified the levels of
the encoded proteins by western blotting of total proteins from
nls and sid cells treated with dox for 0, 24, and 72 h. Although
fluctuations in protein levels could be detected for some factors,
they likely derived from a general, short-term response to dox, as
they were observed in all cell lines and only at 24 h of treatment
(Fig. 6c). No specific alteration in protein levels could be detected
in sid1 and sid4 cells at any time points (Fig. 6c). This confirms
that the effects exerted by SID4X-fused T-TALEs on telomere
stability and ALT activity derive from TERRA transcription
suppression and not from deregulated off-target transcripts.
Discussion
We have developed an efficient system to suppress TERRA
transcription from several chromosome ends in an ALT cell line.
Fig. 4 TERRA transcription inhibition diminishes the frequencies of DLead chromosome ends. a Schematic representation of telomeric features scored in
CO-FISH experiments. DLead: sister telomeres with 2 leading and one lagging strand signals; DLagg: sister telomeres with 2 lagging and one leading strand
signals; TSCEs: telomeric sister chromatid exchanges. b Examples of CO-FISH on metaphases from sid4 cells treated with dox for 72 h. Leading and lagging
strand telomeres are in red and green, respectively; DAPI-stained DNA is in blue. Red arrowheads point to DLeads, green arrowheads to DLaggs, and
yellow arrows to TSCEs. Scale bar: 5 μm. A chromosome with one DLead and one TSCE at its two opposite ends is shown at a 3-fold magnification at the
bottom. c Quantifications of telomeric features in CO-FISH experiments as in b. A total of at least 2538 chromosomes from 3 independent experiments
were analyzed for each condition. Bars and error bars are means and SEMs. Circles are single data points. P-values were calculated with a two-tailed
Student’s t-test. P1= 0.0268. d Speculative model for DLead generation. Scissors represent structure-specific endonucleases. See the “Discussion” section
for details. Source data are provided as a Source Data file.
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Importantly, rapid suppression of TERRA transcription across a
cell population provides the critical advantage to study the
immediate consequences on telomere homeostasis, avoiding
secondary effects associated with clonal selection and expansion
after TERRA inhibition.
Our findings unmistakably settle that multiple chromosome
ends are actively transcribed and further validate that the pre-
viously identified 29 bp repeats are functional and physiologically
relevant TERRA promoters2. The lack of major changes in total
UUAGGG levels in dox-treated sid1 and sid4 cells indicates that
TERRA transcribed from 29 bp repeat promoters does not
majorly contribute to the cellular UUAGGG pool, either because
promoters other than the 29 bp repeats have a stronger tran-
scriptional activity or because TERRA from 29 bp repeat pro-
moters has a shorter half-life. While previous data suggest that
20q-TERRA may be the major contributor to the cellular
UUAGGG pool23,24, the diminished levels of cellular UUAGGG
repeats in 20q-TERRA KO cells might also derive from the short
telomeres in those cells and/or clonal variability. It would be
interesting to systematically deplete TERRA transcripts from
different chromosome ends, including 20q, and measure total
cellular UUAGGG repeats over a short period of time. A com-
parison between the stability of TERRA transcripts from different
subtelomeres should also help clarify this matter.
Our data establish that TERRA transcription inhibition impairs
the accumulation of DNA instability markers (RPA32 and
γH2AX) at telomeres, weakens ALT features (APBs and POLD3-
dependent synthesis of telomeric DNA in G2 cells), and causes
TFE generation. We propose that, in ALT cells, TERRA tran-
scription is a major trigger of replication stress-associated telo-
mere instability and, in turn, BIR-mediated telomere elongation.
The only partial decrease in telomere instability and ALT activity
Fig. 5 TERRA transcription inhibition leads to accumulation of TFEs. a Examples of telomeric DNA FISH on metaphases from the indicated cell lines. For
TERRA transcription inhibition, nls3, sid1, and sid4 cells were treated with dox for up to 15 days (d). For POLD3 depletion, T-REx-U2OS cells were
transfected twice three days apart with two independent siRNAs against POLD3 (siPD3a and siPD3c) or with control siRNAs (siCt) and harvested 6 days
from the first transfection. Telomeric repeat DNA is in red, DAPI-stained chromosomal DNA in blue. White arrowheads point to chromosome arms with
TFEs. Scale bar: 10 μm. b Quantifications of experiments as in a. Boxplots represent the medians (middle lines) and the first and third quartiles (boxes), the
whiskers extend to the 90th percentile of the values. A total of at least 2761 chromosomes from 2 or 3 independent experiments were analyzed for each
condition. P-values were calculated with a two-tailed Mann–Whitney U test. P1= 0.0092; P2= 0.0109; P3= < 0.0001; P4 < 0.0001; P5 < 0.0001; P6 <
0.0001; P7 < 0.0001. Source data are provided as a Source Data file.
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observed in dox-treated sid1 and sid4 cells is most likely
explained by the fact that T-TALEs target a subset of telomeres
and/or the existence of additional telomere instability triggers, for
example, G-quadruplex structures25. Based on previous studies
on RNAseH enzymes8,37 and FANCM9 and the ability of R-loops
to induce DNA instability38, it seems likely that TERRA tran-
scription causes replication stress by stalling the replication fork
through telR-loop formation. It is also possible that telomere
instability derives from the collision between TERRA transcrip-
tion and telomeric replication forks. Importantly, our data chal-
lenge the notion that TERRA supports ALT by capping telomeres,
as it was previously proposed based on the massive accumulation
of telomeric DNA damage in 20q-TERRA KO cells24. On the
contrary, our studies indicate that the immediate result of TERRA
transcription is the active destabilization of ALT telomere integ-
rity to support elongation and cell immortality. Nonetheless, we
do not exclude that chromatin-associated (UUAGGG)n
sequences might also be part of the telomeric cap in ALT and
non-ALT cells as previously suggested7,24,39. Moreover, although
our T-TALEs do not affect 20q-TERRA transcription, which is
expected because the 20q subtelomere does not contain 29 bp
repeats, impaired telomere maintenance is observed both in our
system and in 20q-TERRA KO cells; this suggests that many if
not all telomeres in a cell have to stay transcriptionally active to
ensure fully effective ALT activity.
It is interesting that not all tested ALT features, including C-
circles, are affected when TERRA transcription is inhibited. Two
alternative BIR pathways have been shown to co-exist in
ALT cells, one RAD52-independent and associated with C-circle
production, and the other RAD52-dependent and not leading to
C-circle production29. It is possible that TERRA only supports
RAD52-dependent BIR, although this hypothesis is not consistent
with the observed C-circle accumulation in RNaseH1- and
FANCM-depleted ALT cells8,9,30,31. We thus consider that mild
Fig. 6 TERRA transcription inhibition leads to transcriptomic changes. a Volcano plot of RNA-seq transcriptome data displaying the pattern of gene
expression values in the comparison of sid4 cells treated with dox for 72 h versus untreated sid4 cells. Significantly differentially expressed genes (P≤ 0.05
of Benjamini–Hochberg correction of nominal P-values obtained from the applied two-sided Wald test) are in red. Genes involved in DNA metabolism are
indicated. b Bar plot representation of the Gene Ontology analysis of differentially expressed genes identifying significantly enriched biological process
functional categories (FDR P≤ 0.05). Statistical significance for each term is indicated on the X axis by the −log10 of the FDR P-value. c Western blot
analysis of DNA metabolism factors identified in a. The indicated cell lines were treated with dox for 24 or 72 h or left untreated. Images are from different
identical membranes. PCNA, Beta Actin (ACTB) and Lamin B1 (LMNB1) serve as loading controls. For HROB, the two asterisks indicate variants 1 and 4, the
single asterisk variant 3. Images are representative of experiments repeated at least twice. Source data are provided as a Source Data file.
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changes in C-circles upon partial TERRA transcription inhibition
may fall below the detection limit of our assays. This limitation
would not be unprecedented; for example, in a previous report,
siRNA-mediated depletion of POLD3 in U2OS cells did not
detectably affect C-circle levels while impairing telomeric BIR27.
Combining our T-TALE system with POLD3, RAD52, FANCM,
or RNaseH1 inactivation should elucidate how TERRA tran-
scription and C-circle generation communicate.
TSCEs are also not affected when TERRA transcription is
inhibited. This observation was surprising because 20q-TERRA
KO cells are characterized by diminished TSCE frequencies24.
However, a substantial fraction of the overall short telomeres in
20q-TERRA KO cells might have escaped detection in CO-FISH
experiments, thus skewing the results and their interpretation.
Regardless, our analysis in T-TALE cells revealed that TERRA
transcription promotes the formation of rearranged chromosome
ends with leading strand replication DNA present at both sisters
(DLeads); hence, the mechanisms leading to TSCEs and DLeads
are different. Because TERRA transcription promotes telomeric
BIR, we interpret DLead structures as the outcome of premature
termination of post-replicative BIR events initiating with a lag-
ging strand telomere invading a leading strand one from another
chromosome (Fig. 4d). As soon as a D-loop is formed, it could be
resolved by structure-specific endonucleases, for example, the
SMX complex, which has been previously implicated in ALT40–44.
Endonucleolytic cleavage followed by end-joining would trans-
locate the distal part of the leading strand telomere onto the
lagging strand one, thus generating a DLead structure (Fig. 4d).
Supporting this hypothesis, unequal exchanges of sister telomeres
were also observed in ALT cells depleted of POLD3 in absence of
detectable changes in equal TSCE frequencies27.
Events where lagging strand telomeres translocate onto leading
strand ones, thereby generating DLagg ends, also seem to occur.
However, because TERRA transcription inhibition does not affect
DLagg frequencies, different molecular triggers appear to act at
leading and lagging strand telomeres to initiate BIR. The speci-
ficity of TERRA transcription on DLead frequencies can be
explained in two alternatives, not mutually exclusive ways. One
possibility is that TERRA transcription increases the propensity
of lagging strand telomeres to invade other chromosome ends, for
example by inducing replication fork stalling and DSBs through
telR-loop formation38. Because telR-loops, at least in budding
yeast, are more abundant at short telomeres36, this might con-
stitute a regulatory mechanism directing ALT toward the shortest
telomeres in the cell. Otherwise, TERRA transcription could
prime leading strand telomeres to act as templates for BIR by
altering their structure; this also could depend on the formation
of telR-loops, as they might shape the double helix into an ideal
entry platform for an annealing reaction involving a switch
between TERRA and the 3′ end of the acceptor telomere. This
second hypothesis is supported by the observation that, in
ALT cells, aberrant telR-loop accumulation due to RNAseH1
depletion causes rapid loss of leading strand telomeres8.
This work also opens new questions that should be addressed in
the future. Our experimental settings cannot tell whether TERRA
induces telomere instability in cis or in trans; this is a very relevant
question considering the recently reported propensity of
(UUAGGG)n RNA sequences produced from a transfected plas-
mid to be recruited to telomeres through RAD51-mediated R-loop
formation45. Because T-TALE expression does not alter total
cellular UUAGGG levels and RAD51 is dispensable for ALT
BIR27,29, it seems more likely that TERRA transcription regulates
telomere stability and ALT activity mainly in cis. However,
experimental systems able to discriminate between individual
chromosome ends, containing or devoid of 29 bp repeats, should
be employed to address this question rigorously. It will also be
important to explore the connections, suggested by our tran-
scriptomic data, between TERRA transcription and autophagy- or
apoptosis-mediated cell death. A deeper characterization of this
puzzle piece will tell whether TERRA transcription suppression,
for example through chemical inhibition of TERRA promoter
activity, could spearhead novel therapeutic strategies for the
selective killing of ALT cancer cells.
Methods
Plasmid construction. A repeat-variable di-residue (RVD) domain specifically
targeting the 5′-CTCTGCGCCTGCGCCGGCGC-3′ sequence within the 29 bp
repeat consensus sequence was designed using TAL Effector Targeter46. Variable
numbers of the target 20 bp sequence are identified within the most distal 3 kb of
20 subtelomeres according to a complete clone-based assembly of human sub-
telomeric regions47. A 3560 bp DNA fragment corresponding to a full TALE
module comprising the designed RVD followed by an SV40 nuclear localization
signal and a human influenza hemagglutinin (HA) tag was synthesized at Gen-
Script. The fragment was cloned into a KpnI/ApaI digested pcDNA5-FRT-TO
plasmid (ThermoFisher Scientific) downstream of a doxycycline-inducible CMV
promoter (unfused T-TALE). The obtained plasmid was digested with ClaI and
EcoRV and ligated to a 429 bp fragment comprising the Enhanced Repressor
Domain and synthesized at GenScript (SID4X T-TALE). Plasmid sequences are
available upon request.
Cell culture procedures. T-TALE expressing cells were generated by FRT-
mediated integration of unfused T-TALE and SID4X T-TALE plasmids into
T-REx™-U2OS cells expressing the TetR protein (ThermoFisher Scientific). Clonal
selection was performed by plating cells at low dilution in high glucose DMEM,
GlutaMAX (ThermoFisher Scientific) supplemented with 10% tetracycline-free
fetal bovine serum (Pan BioTech), 100 U/ml penicillin-streptomycin (Thermo-
Fisher Scientific) and 200 μg/ml hygromycin B (VWR). Individual clones were
manually picked and expanded in the same medium. For T-TALE induction,
50 ng/ml doxycycline (dox; Sigma-Aldrich) was added to the culture medium
devoid of hygromycin B for 24–72 h; for longer induction times, dox was refreshed
every 72 h. Mycoplasma contaminations were tested using the LookOut Myco-
plasma PCR Detection Kit (Sigma-Aldrich) according to the manufacturer’s
instructions. When indicated, cells were treated with 1 μM camptothecin (Sigma-
Aldrich) for 6 h. For POLD3 depletion, siRNAs were purchased from Integrated
DNA Technologies and transfected twice three days apart at 30 nM concentration
using the Lipofectamine RNAiMAX reagent (Invitrogen). Target sequences were:
siCt (control): 5′-AUACGCGUAUUAUACGCGAUUAAC-3′; siPD3a: 5′-GAAUU
GUUAGUAGGUCUAAAC-3′; siPD3c: 5′-CCAAAGCUGCUGCUAAAACCC-3′.
Fluorescence-activated cell sorting (FACS). Cells were trypsinized and pelleted
by centrifugation at 500 × g at 4 °C for 5 min. Cell pellets were fixed in 70% ethanol
at −20 °C for 30 min and treated with 25 μg/ml RNaseA (Sigma-Aldrich) in 1×
PBS at 37 °C for 20 min. Cells were then centrifuged as above and pellets washed in
1× PBS and stained with 20 μg/ml propidium iodide (Sigma-Aldrich) in 1× PBS at
4 °C for 10 min. Flow cytometry was performed on a BD Accuri C6 (BD Bios-
ciences). Data were analyzed using FlowJo software. The utilized gating strategy is
shown in Supplementary Fig. 3c.
Western blotting. Cells were trypsinized and pelleted by centrifugation at 500×g at
4 °C for 5 min. Pellets were resuspended in 2× lysis buffer (4% SDS, 20% Glycerol,
120 mM Tris-HCl pH 6.8), boiled at 95 °C for 5 min and centrifuged at 1600×g at
4 °C for 10 min. Supernatants were recovered and protein concentrations deter-
mined by Lowry assay using bovine serum albumin (Sigma-Aldrich) as a standard.
30 μg of proteins were mixed with 0.004% Bromophenol blue and 1%
β-Mercaptoethanol (Sigma-Aldrich), incubated at 95 °C for 5 min, separated in
polyacrylamide gels, and transferred to nitrocellulose membranes (Maine Manu-
facturing, LLC) using a Trans-Blot SD Semi-Dry Transfer Cell apparatus (Bio-
Rad). The following primary antibodies were used: a rabbit monoclonal anti-HA
(Cell Signaling, 3724; 1:1000 dilution), a rabbit polyclonal anti-RAP1 (Bethyl,
A300-306A; 1:2000), a mouse monoclonal anti-PCNA (Santa Cruz Biotechnology,
sc-56; 1:10000), a rabbit polyclonal anti-TRF2 (Novus Biologicals, NB110-57130;
1:2000), a mouse monoclonal anti-POLD3 (Novus Biologicals, H00010714-M01;
1:500), a mouse monoclonal anti-ACTB (Santa Cruz Biotechnology, sc-47778;
1:2000), a mouse monoclonal anti-PML (Santa Cruz Biotechnology, sc-966; 1:500),
a rabbit polyclonal anti-pSer33 (Bethyl, A300-246A; 1:2000), a rabbit polyclonal
anti-RPA32 (Bethyl, A300-244A; 1:1000), a rabbit polyclonal anti-LMB1 (GeneTex,
GTX103292S; 1:5000), a rabbit polyclonal anti-H3 (Santa Cruz Biotechnology, sc-
10809; 1:4000), a mouse monoclonal anti-γH2AX (Millipore, 05-636; 1:2000), a
rabbit polyclonal anti-BLM (Bethyl Laboratories, A300-110A; 1:3000), a rabbit
polyclonal anti-HROB (Atlas Antibodies, HPA023393; 1:1000), a mouse mono-
clonal anti-BRCA1 (Santa Cruz Biotechnology, sc-6954; 1:1000), a mouse
monoclonal anti-EXO1 (Santa Cruz Biotechnology, sc-56092; 1:500), a mouse
monoclonal anti-FANCD2 (Santa Cruz Biotechnology, sc-20022; 1:500), a rabbit
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polyclonal anti-GEN1 (Atlas Antibodies, HPA020078; 1:1000), a rabbit polyclonal
anti-RAD51AP1 (GeneTex, GTX115455; 1:2000), a mouse monoclonal anti-
BRCA2 (Sigma-Aldrich, OP95; 1:2000), a mouse monoclonal anti-ORC1 (Santa
Cruz Biotechnology, sc-398734; 1:500), a rat monoclonal anti-ORC6 (Santa Cruz
Biotechnology, sc-32735; 1:500), a rabbit monoclonal anti-LIG4 (Abcam,
ab193353; 1:2000). Secondary antibodies were HRP-conjugated goat anti-mouse
(Bethyl Laboratories, A90-116P; 1:3000), anti-rabbit (Bethyl Laboratories, A120-
101P; 1:3000), and anti-rat (Santa Cruz Biotechnology, sc-2006; 1:5000) IgGs.
Signals were acquired using an Amersham 680 blot and gel Imager.
DNA fluorescence in situ hybridization (FISH) and chromosome orientation
FISH (CO-FISH). Metaphase spreads were prepared by incubating cells with
200 ng/ml Colchicine (Sigma-Aldrich) for 5 h. Mitotic cells were harvested by
shake-off and incubated in 0.075 M KCl at 37 °C for 10 min. Chromosomes were
fixed in ice-cold methanol/acetic acid (3:1) and spread on glass slides. Slides were
treated with 20 μg/ml RNaseA (Sigma-Aldrich), in 1× PBS at 37 °C for 1 h, fixed in
4% formaldehyde (Sigma-Aldrich) in 1× PBS for 2 min, and treated with 70 μg/ml
pepsin (Sigma-Aldrich) in 2 mM glycine, pH 2 (Sigma-Aldrich) at 37 °C for 5 min.
Slides were fixed again with 4% formaldehyde in 1× PBS for 2 min, incubated
subsequently in 70%, 90%, and 100% ethanol for 5 min each, and air-dried. A C-
rich telomeric PNA probe (5′-Cy3-OO-CCCTAACCCTAACCCTAA-3′; Pana-
gene) diluted in hybridization solution (10 mM Tris-HCl pH 7.2, 70% formamide,
0.5% blocking solution (Roche)) was applied onto the slides followed by incubation
at 80 °C for 5 min and at room temperature for 2 h. Slides were washed twice in
10 mM Tris-HCl pH 7.2, 70% formamide, 0.1% BSA and three times in 0.1 M Tris-
HCl pH 7.2, 0.15M NaCl, 0.08% Tween-20 at room temperature for 10 min each.
For CO-FISH, cells were incubated with BrdU:BrdC (3:1, final concentration
10 μM; Sigma-Aldrich) for 16 h prior to metaphase preparation as above. Chro-
mosomes were spread on glass slides, treated with RNaseA as above, and incubated
with 10 μg/ml Hoechst 33258 (Invitrogen) in 2× SSC for 15 min at room tem-
perature. Slides were exposed to 365-nm ultraviolet light using a Stratagene Stra-
talinker 1800 UV irradiator set to 5400 J, and incubated with 3 U/μl Exonuclease III
(New England Biolabs) at 37 °C for 30 min. Subsequent hybridizations were per-
formed in 30% formamide, 2× SSC for 3 h at room temperature using first a C-rich
telomeric LNA probe (5′-6-FAM-CCCTAACCCTAACCCTAA-3′; Exiqon) and
then a G-rich telomeric LNA probe (5′-TYE563-TTAGGGTTAGGGTTAGGG;
Exiqon). After each hybridization, slides were washed three times in 2× SSC at
room temperature for 10 min. Both for FISH and CO-FISH, DNA was counter-
stained with 100 ng/ml DAPI (Sigma-Aldrich) in 1× PBS, and slides were mounted
in Vectashield (Vectorlabs). Images were acquired with a Zeiss Cell Observer
equipped with a cooled Axiocam 506m camera and a ×63/1.4NA oil DIC M27
PlanApo N objective. Image analysis was performed using ImageJ and Photoshop
software.
EdU incorporation and detection at telomeres. Cells grown on coverslips were
incubated in a medium containing 2 mM Thymidine (Sigma-Aldrich) for 21 h
before replacement with fresh dox-containing medium. After 4 h, 10 μM RO-3306
(Selleckchem) was added, and 18 h later 10 μM EdU (ThermoFisher Scientific) was
added to the culture medium, followed by a 2.5 h incubation. Cells were hybridized
as for DNA FISH, washed twice with 1× PBS, and EdU was detected using the
Click-iT EdU Alexa Fluor 488 Imaging Kit (ThermoFisher Scientific) according to
the manufacturer’s instructions. DNA was counterstained with 100 ng/ml DAPI in
1× PBS and coverslips were mounted on slides in Vectashield. Image acquisition
and analysis were as for DNA FISH.
Indirect immunofluorescence (IF). For HA detection, cells grown on coverslips
were incubated in 100% Methanol (Merk) at −20 °C for 15 min. For all other IF
experiments, cells were incubated in CSK buffer (100 mM NaCl, 300 mM sucrose,
3 mM MgCl2, 0.5% Triton X-100, 10 mM PIPES pH 7) for 7 min on ice, fixed with
4% formaldehyde (Sigma-Aldrich) in 1× PBS for 10 min and permeabilized again
with CSK buffer for 5 min. Fixed cells were incubated in blocking solution (0.5%
BSA, 0.1% Tween-20 in 1× PBS) for 1 h followed by incubation in blocking
solution containing primary antibodies for 1 h, three washes with 0.1% Tween-20
in 1× PBS for 10 min each, and incubation with secondary antibodies diluted in
blocking solution for 50 min. For combined IF and DNA FISH, cells were again
fixed with 4% formaldehyde in 1× PBS for 10 min, washed three times with 1× PBS,
incubated in 10 mM Tris-HCl pH 7.2 for 5 min and then denatured and hybridized
with a PNA probe (5′-AF568-OO-CCCTAACCCTAACCCTAA-3′; Panagene) as
for DNA FISH. DNA was counterstained with 100 ng/ml DAPI in 1× PBS or in
0.1 M Tris-HCl pH 7.2, 0.15 M NaCl, 0.08% Tween-20. Coverslips were mounted
on slides in Vectashield. The following primary antibodies were used: a rabbit
monoclonal anti-HA (Cell Signaling, 3724; 1:1000 dilution), a rabbit polyclonal
anti-RAP1 (Bethyl, A300-306A; 1:2000), a mouse monoclonal anti-TRF2 (Milli-
pore, 05-521; 1:2000), a mouse monoclonal anti-POLD3 (Novus Biologicals,
H00010714-M01; 1:500), a mouse monoclonal anti-PML (Santa Cruz Bio-
technology, sc-966; 1:500), a rabbit polyclonal anti-pSer33 (Bethyl, A300-246A;
1:2000), a rabbit polyclonal anti-RPA32 (Bethyl, A300-244A; 1:1000), a mouse
monoclonal anti-γH2AX (Millipore, 05-636; 1:2000). Secondary antibodies were
Alexa Fluor 568-conjugated donkey anti-rabbit IgGs (ThermoFisher Scientific,
A10042; 1:1000) and Alexa Fluor 488-conjugated donkey anti-mouse IgGs
(ThermoFisher Scientific, A21202; 1.1000). Image acquisition and analysis were as
for DNA FISH.
Chromatin immunoprecipitation (ChIP). Cells were harvested by trypsinization,
centrifuged at 500×g at 4 °C for 5 min, and resuspended in 1% formaldehyde
(Sigma-Aldrich) for 20 min at room temperature, followed by quenching with
125 mM glycine (VWR) for 5 min. Cross-linked cells were centrifuged as above and
pellets were resuspended in ChIP lysis buffer (1% SDS, 10 mM EDTA, 50 mM Tris-
HCl pH 8), sonicated using a Bioruptor apparatus (Diagenode) and centrifuged at
16,000×g for 10 min at 4 °C. 1 mg of lysate was diluted in ChIP dilution buffer
(150 mM NaCl, 20 mM Tris-HCl pH 8, 1% Triton X-100, 2 mM EDTA) and
incubated with 2 μg of a rabbit monoclonal anti-HA antibody (Cell Signaling,
3724) for 2 h at room temperature. Immunocomplexes were isolated by incubation
with Protein A/G PLUS-Agarose beads (Santa Cruz Biotechnology) at 4 °C over-
night on a rotating wheel. Beads were washed 4 times in ChIP wash buffer
(150 mM NaCl, 20 mM Tris-HCl pH 8, 1% Triton X-100, 0.1% SDS, 2 mM EDTA)
and once in ChIP final wash buffer (500 mM NaCl, 20 mM Tris-HCl pH 8, 1%
Triton X-100, 0.1% SDS, 2 mM EDTA). Beads were incubated in ChIP elution
buffer (1% SDS, 100 mM NaHCO3) containing 40 μg/ml RNaseA (Sigma-Aldrich)
for 1 h at 37 °C and DNA was extracted using the Wizard SV gel and PCR cleanup
system (Promega). Input and immunoprecipitated DNA was subjected to quanti-
tative PCR using the oligonucleotides shown in Supplementary Table 1. QPCRs
were performed using the iTaq Universal SYBR Green Supermix (Bio-Rad) on a
Rotor-Gene Q (Qiagen) instrument with a 2-step program (45 cycles of dena-
turation at 95 °C for 15 s, annealing and extension at 60 °C for 30 s). Data analysis
was performed using the Rotor-Gene 6000 Series Software 1.7.
RNA preparation and analysis. Total RNA was isolated using the TRIzol reagent
(ThermoFisher Scientific) followed by chloroform extraction and treated three
times with 3.5 U of DNaseI (Qiagen) for 45 min at room temperature. For RT-
qPCR, 5 μg of RNA were reverse transcribed with 0.5 μM TeloR and 0.05 μM
ActinR oligonucleotides (Supplementary Table 1) and Superscript III (Thermo-
Fisher Scientific) according to the manufacturer’s instructions. Quantitative PCRs
were performed and analyzed for ChIP using the oligonucleotides shown in Sup-
plementary Table 1. Actin values were used as normalizers. For northern blotting,
15 μg of RNA were separated in 1.2% agarose gels containing 0.7% formaldehyde
and transferred onto nylon membranes. When indicated, gels were incubated with
50 mM NaOH, 1.5 M NaCl for 10 min at room temperature prior to transfer. To
detect total TERRA (UUAGGG pool), RNA was hybridized at 55 °C overnight with
a double-stranded telomeric probe (Telo2 probe) radioactively labeled using Kle-
now fragment (New England Biolabs) and [α-32P]dCTP. Post-hybridization washes
were twice in 2× SSC, 0.2% SDS for 20 min and once in 0.2× SSC, 0.2% SDS for
30 min at 55 °C. After the radioactive signal acquisition, membranes were stripped
and re-hybridized at 50 °C overnight with the Actin_2 oligonucleotide (Supple-
mentary Table 1) radioactively labeled using T4 Polynucleotide Kinase (New
England Biolabs) and [γ-32P]ATP. Post-hybridization washes were twice in 2×
SSC, 0.2% SDS for 20 min and once in 1× SSC, 0.2% SDS for 30 min at 50 °C.
Radioactive signals were detected using a Typhoon FLA 9000 imager (GE
Healthcare) and quantified using ImageJ software.
Genomic DNA preparation and analysis. Genomic DNA was isolated by phenol:
chloroform extraction and treatment with 40 μg/ml RNaseA (Sigma-Aldrich),
followed by ethanol precipitation. Reconstituted DNA was digested with HinfI and
RsaI (New England Biolabs) and again purified by phenol:chloroform extraction.
For PFGE, 4 μg of digested DNA were separated in a 1% agarose gel at 15 °C for
21 h (6 V/cm, switch time 5 s, included angle 120°) using a CHEF-DRIII system
(Bio-Rad). Gels were dried and hybridized with a radioactively labeled Telo2 probe
for northern blotting. For C-circle assays, 500 ng of digested DNA were incubated
with 7.5 U of phi29 DNA polymerase (New England Biolabs) in presence of dATP,
dTTP, and dGTP (1 mM each) at 30 °C for 8 h, followed by heat-inactivation at
65 °C for 20 min. Amplification products were dot-blotted onto nylon membranes
(GE Healthcare) and hybridized with a radioactively labeled Telo2 probe as for
northern blotting. Radioactive signals were detected using a Typhoon FLA 9000
imager (GE Healthcare) and quantified using ImageJ software.
Statistical analysis. For direct comparison of two groups, we employed a paired
two-tailed Student’s t-test using Microsoft Excel or a nonparametric two-tailed
Mann–Whitney U test using GraphPad Prism. P-values are indicated in figure
legends.
RNA-seq. Triplicate cultures of sid4 and nls3 cells were treated with dox for 3 days
or left untreated. Total RNA extracted as above was subjected to rRNA removal
and sequencing using a HiSeq 4000 Illumina sequencer at Novogene Co., Ltd.
Approximately 50 million reads per replicate were obtained applying a paired-end
protocol (2 × 150 bp). Raw reads were subjected to standard quality control pro-
cedures with the FastQC software (v.0.11.8; https://www.bioinformatics.babraham.
ac.uk/projects/fastqc/) and aligned to the human genome reference sequence
(NCBI38/hg38) with the RNA STAR alignment software (v.2.7.7a)48. Genes were
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annotated with respect to the GENCODE basic annotation v.36 and quantified
with the featureCounts tool (v.2.0.1)49. Differential gene expression analysis was
performed with DESeq2 (v. 2.11.40.6)50 and differentially expressed genes were
selected applying a statistical threshold of 0.05 of the Benjamini–Hochberg cor-
rected P-value. The functional enrichment analyses of differentially expressed genes
were performed using the Database for Annotation, Visualization and Integrated
Discovery (DAVID, v.6.8)51. Volcano and bar plots were generated with the R
package ggplot252, bubble plots were generated with the R package GOplot53.
Reporting summary. Further information on research design is available in the Nature
Research Reporting Summary linked to this article.
Data availability
All raw RNA sequencing data are publicly available through the NCBI Sequence Read
Archive (BioProject ID: PRJNA699729). All other relevant data supporting the findings
of this study are available within the paper and its Supplementary Information files or
upon request. Source data are provided with this paper.
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